Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 268-273 , May 2010

Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE™

  • Y. Mark Hong, M.D.

      Affiliations

    • Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-947-7170; fax: +1-202-741-3114
    • ,
  • Jim C. Hu, M.D., MPH

      Affiliations

    • Division of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02114, USA
    • ,
  • Alan T. Paciorek, B.S.

      Affiliations

    • Department of Urology, University of California-San Francisco, San Francisco, CA 94143, USA
    • ,
  • Sara J. Knight, Ph.D.

      Affiliations

    • Department of Psychiatry, University of California-San Francisco, San Francisco, CA 94143, USA
    • ,
  • Peter R. Carroll, M.D.

      Affiliations

    • Department of Urology, University of California-San Francisco, San Francisco, CA 94143, USA

Received 14 June 2008 ,Revised 10 July 2008

References 

  1. Deimling GT, Bowman KF, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15:306–330
  2. Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma: A pilot study. Cancer. 1998;82:1904–1908
  3. Dale W, Bilir P, Han M, et al. The role of anxiety in prostate carcinoma: A structured review of the literature. Cancer. 2005;104:467–478
  4. Latini DM, Hart SL, Knight SJ, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007;178:826–832
  5. Mehta SS, Lubeck DP, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE™. J Urol. 2003;170:1931–1933
  6. Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality, and the impact of demographic, oncologic, and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–286
  7. Leake RL, Gurrin LC, Hammond IG. Quality of life in patients attending a low-risk gynecological oncology follow-up clinic. Psychooncology. 2001;10:428–435
  8. Humphris GM, Rogers S, McNally D, et al. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32:486–491
  9. Clark JA, Inui TS, Silliman RA, et al. Patient's perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol. 2003;21:3777–3784
  10. Swindle P, Eastham JA, Ohori M, et al. Do margins matter? (The prognostic significance of positive surgical margins in radical prostatectomy specimens). J Urol. 2005;194:903–907
  11. Karakiewicz PI, Eastham JA, Graefen M, et al. Prognostic impact of surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients. Urology. 2005;66:1245–1250
  12. Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States: Lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol. 2004;171:1393–1401
  13. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) (I. Conceptual framework and item selection). Med Care. 1992;30:473–483
  14. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–1012
  15. Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007;177:540–545
  16. Greenberg DB, Kornblith A, Herndon JE, et al. Quality of life of adult leukemia survivors treated on clinical trials of the Cancer and Leukemia Group B from 1971 to 1988: Predictions for later psychological distress. Cancer. 1997;80:1936–1944
  17. Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long-term psychosocial functioning of childhood acute leukemia survivors treated by intrathecal methotrexate with and without cranial radiation. Cancer. 1998;82:208–218
  18. Montgomery DC. Experiments with Random Factors. In:  Montgomery DC editors. Design and Analysis of Experiments. Hoboken: John Wiley and Sons; 2005;p. 484
  19. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–974
  20. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: Further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47:340–347
  21. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  22. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA. 2006;15:2329–2335

☆ This work was funded by an educational grant from TAP Pharmaceuticals.

PII: S1078-1439(08)00162-2

doi: 10.1016/j.urolonc.2008.07.004

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 3 , Pages 268-273 , May 2010

Article Tools

* Image Usage & Resolution